Press launch MHRA approves GLP –one receptor agonist semaglutide to scale back danger of significant coronary heart issues in obese or overweight Grown ups Semaglutide is the 1st fat loss drug accredited in britain like a preventative remedy for those with set up cardiovascular diseaseMainly because Wegovy, Mounjaro and copyright pens all consist